CLEVELANDMarconi Medical Systems has received 510k clearance
from the FDA to market its new ACQSIM CT scanner that addresses the
special needs of oncology CT simulation and planning.
The ACQSIM CT scanner is designed with an 85-cm large bore, to
simplify planning difficult cases, including breast, Hodgkins
lymphoma, and large patients.
The acQsim system includes a high-precision localization and marking
system and a virtual simulator that yield digitally composited and/or
reconstructed radiographs that exceed the requirements of conformal
and high-precision radiotherapy delivery, the company said.
The footprint of the new scanner is the same as that of standard
70-cm diagnostic CTs and is designed to fit into rooms that currently
house a conventional simulator or CT scanner.
Several sites will be installed in 2000, the company said, with
general product release scheduled for the spring of 2001.